180 related articles for article (PubMed ID: 18486048)
1. Linezolid.
Tuberculosis (Edinb); 2008 Mar; 88(2):122-5. PubMed ID: 18486048
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.
Wallis RS; Jakubiec WM; Kumar V; Silvia AM; Paige D; Dimitrova D; Li X; Ladutko L; Campbell S; Friedland G; Mitton-Fry M; Miller PF
J Infect Dis; 2010 Sep; 202(5):745-51. PubMed ID: 20629533
[TBL] [Abstract][Full Text] [Related]
3. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Sotgiu G; Centis R; D'Ambrosio L; Castiglia P; Migliori GB
Eur Respir J; 2015 Jan; 45(1):287-9. PubMed ID: 25552740
[No Abstract] [Full Text] [Related]
4. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Weiss T; Schönfeld N; Otto-Knapp R; Bös L; Bettermann G; Mauch H; Bauer TT; Rüssmann H
Eur Respir J; 2015 Jan; 45(1):285-7. PubMed ID: 25552739
[No Abstract] [Full Text] [Related]
5. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Yew WW; Chang KC; Chau CH
J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
[No Abstract] [Full Text] [Related]
6. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
Koh WJ; Shim TS
J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
[No Abstract] [Full Text] [Related]
7. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB;
Eur Respir J; 2013 Jul; 42(1):288-90. PubMed ID: 23813314
[No Abstract] [Full Text] [Related]
8. On linezolid efficacy and tolerability.
De Lorenzo S; Centis R; D'Ambrosio L; Sotgiu G; Migliori GB
Eur Respir J; 2012 Mar; 39(3):770-2. PubMed ID: 22379150
[No Abstract] [Full Text] [Related]
9. Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
Dauby N; Muylle I; Mouchet F; Sergysels R; Payen MC
Pediatr Infect Dis J; 2011 Sep; 30(9):812-3. PubMed ID: 21378593
[TBL] [Abstract][Full Text] [Related]
10. [Linezolid, an agent from a new class of antibiotics].
Slebos DJ; Van Altena R
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2462; author reply 2462-3. PubMed ID: 15626313
[No Abstract] [Full Text] [Related]
11. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
Yew WW; Lange C
Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
[No Abstract] [Full Text] [Related]
12. Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.
Garcia-Prats AJ; Rose PC; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2014 Mar; 94(2):93-104. PubMed ID: 24388605
[TBL] [Abstract][Full Text] [Related]
13. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.
Hui M; Au-Yeang C; Wong KT; Chan CY; Yew WW; Leung CC
Int J Antimicrob Agents; 2008 Apr; 31(4):395-6. PubMed ID: 18272351
[No Abstract] [Full Text] [Related]
14. Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
Maartens G; Benson CA
EBioMedicine; 2015 Nov; 2(11):1568-9. PubMed ID: 26870767
[No Abstract] [Full Text] [Related]
15. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Williams KN; Stover CK; Zhu T; Tasneen R; Tyagi S; Grosset JH; Nuermberger E
Antimicrob Agents Chemother; 2009 Apr; 53(4):1314-9. PubMed ID: 19075058
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
Zhang M; Sala C; Dhar N; Vocat A; Sambandamurthy VK; Sharma S; Marriner G; Balasubramanian V; Cole ST
Antimicrob Agents Chemother; 2014 Jun; 58(6):3217-23. PubMed ID: 24663022
[TBL] [Abstract][Full Text] [Related]
17. Linezolid for multidrug-resistant tuberculosis.
Chang KC; Leung CC; Daley CL
Lancet Infect Dis; 2012 Jul; 12(7):502-3. PubMed ID: 22742623
[No Abstract] [Full Text] [Related]
18. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
[TBL] [Abstract][Full Text] [Related]
19. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis.
Scotton P; Fuser R; Torresan S; Carniato A; Giobbia M; Rossi C; Inojosa WO; Vaglia A
Infection; 2008 Aug; 36(4):387-8. PubMed ID: 18642110
[No Abstract] [Full Text] [Related]
20. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
